RESUMEN

There is growing evidence that GVHD affects the central nervous system (CNS). In this study, we describe the long-term follow-up of four allogeneic BM recipients who developed cerebral angiitis-like disease probably due to GVHD. The patients developed focal neurological signs, cognitive deficits and/or coma in association with GVHD, 2-18 years after transplantation, following reduction of immunosuppressive therapy. Magnetic resonance imaging was variable, showing generalized brain atrophy, ischemic lesions or leukoencephalopathy. Diagnosis of cerebral angiitis was confirmed by histopathological analysis of bioptic brain tissue and response to immunosuppressive therapy. By means of immunohistochemistry and immunofluorescence, perivascular lymphomononuclear cerebral infiltrates were shown to express the adhesion receptor, CD11a, and the chemokine receptor, CCR5. Our findings imply that GVHD should be considered in the differential diagnosis of noninfectious angiitis-like disease of the CNS in long-term survivors after allogeneic BMT. Infiltrating cells, in analogy to typical target organs of GVHD such as skin or liver, expressed CD11a and CCR5. These findings could be of etiopathological, diagnostic and therapeutic relevance.

Asunto(s)

Enfermedad Injerto contra Huésped/complicaciones , Inmunosupresores/farmacología , Vasculitis del Sistema Nervioso Central/diagnóstico , Vasculitis del Sistema Nervioso Central/etiología , Adulto , Trasplante de Médula Ósea/efectos adversos , Antígeno CD11a/análisis , Movimiento Celular/inmunología , Enfermedad Crónica , Diagnóstico Diferencial , Femenino , Enfermedad Injerto contra Huésped/diagnóstico , Humanos , Estudios Longitudinales , Imagen por Resonancia Magnética , Masculino , Receptores CCR5/análisis , Sobrevivientes , Trasplante Homólogo , Vasculitis del Sistema Nervioso Central/patología , Adulto Joven

RESUMEN

CCL19 and CCL21 bind to CCR7, which is crucial for both inducing an immune response and establishing immunological tolerance. We report that in the normal human brain CCL19, but not CCL21, is transcribed, and detectable as a protein in tissue lysates and in cerebrospinal fluid. In both active and inactive multiple sclerosis (MS) lesions CCL19 transcripts were elevated. In cerebrospinal fluid from MS and OIND patients CCL19 protein was increased. In relapsing-remitting and secondary progressive MS patients CCL19 correlated with intrathecal IgG production. This study suggests that CCL19 plays a role in both the physiological immunosurveillance of the healthy CNS and the pathological maintenance of immune cells in the CNS of MS patients.

Asunto(s)

Encéfalo/inmunología , Quimiocina CCL19/inmunología , Encefalitis/inmunología , Esclerosis Múltiple/inmunología , Adulto , Anciano , Encéfalo/fisiopatología , Quimiocina CCL19/líquido cefalorraquídeo , Quimiocina CCL19/genética , Quimiocina CCL21/líquido cefalorraquídeo , Quimiocina CCL21/genética , Quimiocina CCL21/inmunología , Quimiotaxis de Leucocito/genética , Quimiotaxis de Leucocito/inmunología , Encefalitis/líquido cefalorraquídeo , Encefalitis/fisiopatología , Femenino , Humanos , Vigilancia Inmunológica/genética , Vigilancia Inmunológica/inmunología , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/líquido cefalorraquídeo , Esclerosis Múltiple/fisiopatología , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Recurrencia , Regulación hacia Arriba/genética , Regulación hacia Arriba/inmunología

RESUMEN

We examined 103 patients with vestibular neuritis (VN) in a follow-up study (5.7 to 20.5 years, mean 9.8 years). Two patients (1.9%) had developed a second occurrence of VN 29 to 39 months after the first. VN affected the contralateral ear in both and caused less severe distressing vertigo and postural imbalance. Unlike Bell's palsy and sudden hearing loss, a relapse in the same ear did not occur.

Asunto(s)

Nervio Vestibular/fisiopatología , Neuronitis Vestibular/epidemiología , Adulto , Anciano , Parálisis de Bell/epidemiología , Parálisis de Bell/fisiopatología , Comorbilidad , Femenino , Estudios de Seguimiento , Lateralidad Funcional/fisiología , Pérdida Auditiva Sensorineural/etiología , Pérdida Auditiva Sensorineural/fisiopatología , Herpes Simple/complicaciones , Herpes Simple/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos , Factores de Tiempo , Vértigo/etiología , Vértigo/fisiopatología , Nervio Vestibular/patología , Neuronitis Vestibular/diagnóstico , Neuronitis Vestibular/fisiopatología

Asunto(s)

Enfermedad de Crohn/metabolismo , Glicoproteínas/metabolismo , Inmunoglobulinas/metabolismo , Macrófagos/metabolismo , Monocitos/metabolismo , Esclerosis Múltiple/metabolismo , Antígenos CD , Humanos , Receptores de Superficie Celular , Miembro 1 de la Familia de Moléculas Señalizadoras de la Activación Linfocitaria

RESUMEN

Reactivation of herpes simplex virus type 1 (HSV-1) in the vestibular ganglion (VG) is the suspected cause of vestibular neuritis (VN). Recent studies reported the presence of HSV-1 DNA not only in human VGs but also in vestibular nuclei, a finding that indicates the possibility of viral migration to the human vestibular labyrinth. Distribution of HSV-1 DNA was determined in geniculate ganglia, VGs, semicircular canals, and macula organs of 21 randomly obtained human temporal bones by nested PCR. Viral DNA was detected in 48% of the labyrinths, 62% of the VGs, and 57% of the geniculate ganglia. The potential significance of this finding is twofold: (1) Inflammation in VN could also involve the labyrinth and thereby cause acute unilateral vestibular deafferentation. (2) As benign paroxysmal positional vertigo often occurs in patients who have had VN, it could also be a sequel of viral labyrinthitis.

Asunto(s)

Herpes Simple/virología , Herpes Zóster Ótico/virología , Herpesvirus Humano 1 , Adulto , ADN Viral , Herpes Simple/genética , Herpes Zóster Ótico/genética , Humanos , Lactante , Laberintitis/genética , Laberintitis/virología , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Vértigo/etiología , Neuronitis Vestibular/complicaciones , Neuronitis Vestibular/genética , Neuronitis Vestibular/virología

RESUMEN

Herpes simplex virus type 1 (HSV-1) enters sensory neurons and can remain latent there until reactivation. During latency restricted HSV-1 gene expression takes place in the form of latency-associated transcripts (LAT). LAT has been demonstrated to be important not only for latency but also for reactivation, which may cause cranial nerve disorders. Tissue sections of the trigeminal ganglia (TG), geniculate ganglia (GG), and the vestibular ganglia (VG) from seven subjects were examined for the presence of LAT using the in situ hybridization technique. LAT was found on both sides in allTG (100%), on both sides of five subjects (70%) in the GG, and in none of the VG. Using a second more sensitive detection method (RT-PCR), we found LAT in the VG of seven of ten other persons (70%). This is the first study to demonstrate viral latency in the VG, a finding that supports the hypothesis that vestibular neuritis is caused by HSV-1 reactivation. The distribution of LAT in the cranial nerve ganglia indicates that primary infection occurs in the TG and GG and subsequently spreads along the faciovestibular anastomosis to the VG.

Asunto(s)

Enfermedades de los Nervios Craneales/virología , Ganglio Geniculado/virología , Herpes Simple/genética , Herpesvirus Humano 1/genética , ARN Viral/metabolismo , Ganglio del Trigémino/virología , Nervio Vestibular/virología , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades de los Nervios Craneales/patología , Enfermedades de los Nervios Craneales/fisiopatología , Regulación Viral de la Expresión Génica/fisiología , Ganglio Geniculado/patología , Ganglio Geniculado/fisiopatología , Herpes Simple/metabolismo , Herpes Simple/patología , Herpesvirus Humano 1/metabolismo , Herpesvirus Humano 1/patogenicidad , Humanos , Proteínas Inmediatas-Precoces/metabolismo , Hibridación in Situ , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transcripción Genética/genética , Ganglio del Trigémino/patología , Ganglio del Trigémino/fisiopatología , Nervio Vestibular/patología , Nervio Vestibular/fisiopatología , Latencia del Virus/genética

RESUMEN

Although many viruses have been isolated from patients with multiple sclerosis (MS), as yet, no one agent has been demonstrated to cause MS. In contrast, epidemiological data indicate that viral infections are associated with exacerbations of MS. Here, we present data showing that virus infections can subclinically prime animals for central nervous system (CNS) autoimmune disease; long after the original infection has been eradicated, a nonspecific challenge/infection can trigger an exacerbation. The priming infectious agent must show molecular mimicry with self-CNS antigens such as glial fibrillary acidic protein (GFAP), myelin associated glycoprotein (MAG) or myelin proteolipid protein (PLP). The subsequent challenge, however, may be nonspecific; complete Freund's adjuvant (CFA), or infection with a recombinant vaccinia virus encoding an irrelevant protein, could trigger CNS disease. In the CNS, we could detect a mononuclear cell infiltration, but no demyelination was found. However, if the pathogenesis of MS is similar to that of this novel animal model for CNS autoimmune disease, our findings could help explain why exacerbations of MS are often associated with a variety of different viral infections.

Asunto(s)

Enfermedades Desmielinizantes/virología , Encefalomielitis Autoinmune Experimental/virología , Virus Vaccinia/inmunología , Vaccinia/inmunología , Animales , División Celular/inmunología , Enfermedades Desmielinizantes/inmunología , Enfermedades Desmielinizantes/patología , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Linfocitos/citología , Linfocitos/virología , Ratones , Ratones Endogámicos , Imitación Molecular/inmunología , Esclerosis Múltiple/inmunología , Esclerosis Múltiple/patología , Esclerosis Múltiple/virología , Proteína Proteolipídica de la Mielina/genética , Proteína Proteolipídica de la Mielina/inmunología , Plásmidos , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Ubiquitinas/genética , Ubiquitinas/inmunología , Vaccinia/patología , Virus Vaccinia/genética

RESUMEN

Multiple sclerosis (MS) can be divided into 4 clinical forms: relapsing-remitting (RR), primary progressive (PP), secondary progressive (SP), and progressive relapsing (PR). Since PP-MS is notably different from the other forms of MS, both clinically and pathologically, the question arises whether PP-MS is immunologically similar to the other forms. The pathogenesis of the PP-MS remains unclear, partly due to a lack of highly relevant animal models. Using an encephalitogenic peptide from myelin oligodendrocyte glycoprotein (MOG)92-106, we have established animal models that mimic different forms of MS in 2 strains of H-2s mice, SJL/J and A.SW. We induced experimental allergic encephalomyelitis (EAE) using MOG92-106 in the presence or absence of supplemental Bordetella pertussis (BP). Although, SJL/J mice developed RR-EAE whether BP was given or not, A.SW mice developed PP-EAE without BP and SP-EAE with BP. Histologically, SJL/J mice developed mild demyelinating disease with T cell infiltration, while A.SW mice developed large areas of plaque-like demyelination with immunoglobulin deposition and neutrophil infiltration, but with minimal T cell infiltration. In A.SW mice without BP, high titer serum anti-MOG antibody was detected and the anti-MOG IgG2a/IgG1 ratio correlated with survival times of mice. We hypothesized that, in A.SW mice, a Th2 response favors production of myelinotoxic antibodies, leading to progressive forms with early death. Our new models indicate that a single encephalitogen could induce either RR-, PP-, or SP- forms of demyelinating disease in hosts with immunologically different humoral immune responses.

Asunto(s)

Anticuerpos/análisis , Encefalomielitis Autoinmune Experimental/inmunología , Esclerosis Múltiple Crónica Progresiva/inmunología , Esclerosis Múltiple Recurrente-Remitente/inmunología , Animales , Sistema Nervioso Central/patología , ADN Bacteriano/fisiología , Modelos Animales de Enfermedad , Encefalomielitis Autoinmune Experimental/patología , Encefalomielitis Autoinmune Experimental/fisiopatología , Femenino , Inmunoglobulinas/metabolismo , Etiquetado Corte-Fin in Situ , Linfocitos/patología , Ratones , Ratones Mutantes , Proteínas de la Mielina , Glicoproteína Asociada a Mielina/inmunología , Glicoproteína Mielina-Oligodendrócito , Sistema Nervioso/patología , Fragmentos de Péptidos/inmunología , Plásmidos/genética

RESUMEN

DA, GDVII and H101 are neurovirulent strains of Theiler's murine encephalomyelitis virus that cause very different neuropathology and CNS disease when inoculated into SJL/J mice. DA virus causes a chronic demyelinating disease, GDVII virus causes an acute fatal polioencephalomyelitis, and H101 virus causes an acute pachymeningitis with hydrocephalus. Performing RNase protection assays, we detected the same pattern of chemokine (RANTES, MCP-1, IP-10, MIP-1beta, MIP-1alpha and MIP-2) mRNA expression in brain and spinal cord during all three infections. In contrast, IFN-beta and IL-6 mRNA were highly expressed only in GDVII virus infection, whereas high levels of LT-alpha mRNA were only found during DA virus infection. Our study demonstrates that proinflammatory cytokines are involved in the neuropathogenesis of CNS disease and modulate the acute and chronic process underlying different pathologic features of disease.

Asunto(s)

Infecciones por Cardiovirus/metabolismo , Quimiocinas/genética , Citocinas/genética , ARN Mensajero/metabolismo , Theilovirus , Animales , Femenino , Inmunohistoquímica , Ganglios Linfáticos/metabolismo , Ratones , Hibridación de Ácido Nucleico , Ratas , Ratas Endogámicas , Ribonucleasas , Especificidad de la Especie , Theilovirus/genética

RESUMEN

To investigate whether apoptosis contributes to neuronal degeneration in bovine spongiform encephalopathy (BSE), morphological changes consistent with apoptosis were sought and in-situ end labelling (ISEL) was applied, in a series of 20 BSE cases and 10 age-matched normal control cattle. Apoptotic changes were not found in neurons but were occasionally seen in glial cells. Relatively few ISEL-positive neurons were found, but many labelled nuclei were seen in glial cells in certain areas. None of the labelled cells showed morphological features of apoptosis. ISEL(+)cells occurred in areas of spongiform change and other areas of grey matter lacking spongiform change. Some association was found between degree of cellular DNA fragmentation and accumulation of abnormal prion protein (PrP(Sc)). Interestingly, small or moderate numbers of T lymphocytes, not present in the normal central nervous system (CNS), were detected in the CNS parenchyma in most BSE cases. There was a pronounced astrogliosis, but markers of macrophage or microglial activation were only slightly increased. The results indicate that nuclear DNA vulnerability is enhanced in certain neuroanatomical areas in BSE, but evidence that apoptosis plays a role in neuronal loss in BSE was very limited. 1999 Harcourt Publishers Ltd.

Asunto(s)

Tronco Encefálico/patología , Fragmentación del ADN , Encefalopatía Espongiforme Bovina/patología , Animales , Antígenos CD/análisis , Tronco Encefálico/química , Bovinos , Recuento de Células , ADN/análisis , Encefalopatía Espongiforme Bovina/genética , Encefalopatía Espongiforme Bovina/inmunología , Proteína Ácida Fibrilar de la Glía/análisis , Técnicas para Inmunoenzimas/veterinaria , Etiquetado Corte-Fin in Situ/veterinaria , Neuroglía/química , Neuroglía/patología , Neuronas/química , Neuronas/patología , Proteínas PrPSc/análisis , Linfocitos T/patología

RESUMEN

Theiler's murine encephalomyelitis virus (TMEV) infection and relapsing-remitting experimental allergic encephalomyelitis (R-EAE) have been used to investigate the viral and autoimmune etiology of multiple sclerosis (MS), a possible Th1-type mediated disease. DNA immunization is a novel vaccination strategy in which few harmful effects have been reported. Bacterial DNA and oligodeoxynucleotides, which contain CpG motifs, have been reported to enhance immunostimulation. Our objectives were two-fold: first, to ascertain whether plasmid DNA, pCMV, which is widely used as a vector in DNA immunization studies, could exert immunostimulation in vitro; and second, to test if pCMV injection could modulate animal models for MS in vivo. We demonstrated that this bacterially derived DNA could induce interleukin (IL)-12, interferon (IFN)gamma, (Th1-promoting cytokines), and IL-6 production as well as activate NK cells. Following pCMV injections, SJL/J mice were infected with TMEV or challenged with encephalitogenic myelin proteolipid protein (PLP) peptides. pCMV injection exacerbated TMEV-induced demyelinating disease in a dose-dependent manner. Exacerbation of the disease did not correlate with the number of TMEV-antigen positive cells but did with an increase in anti-TMEV antibody. pCMV injection also enhanced R-EAE with increased IFNgamma and IL-6 responses. These results caution the use of DNA vaccination in MS patients and other possible Th1-mediated diseases.

Asunto(s)

ADN Bacteriano/efectos adversos , Esclerosis Múltiple/inmunología , Esclerosis Múltiple/microbiología , Animales , Anticuerpos Antivirales/sangre , Islas de CpG/inmunología , Citocinas/biosíntesis , Citomegalovirus/inmunología , ADN Bacteriano/inmunología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Encefalomielitis Autoinmune Experimental/genética , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Vectores Genéticos/efectos adversos , Vectores Genéticos/inmunología , Inmunoglobulina G/sangre , Células Asesinas Naturales/inmunología , Ratones , Ratones Endogámicos , Esclerosis Múltiple/patología , Proteína Proteolipídica de la Mielina/inmunología , Médula Espinal/patología , Células TH1/inmunología , Theilovirus/inmunología , Vacunas de ADN/efectos adversos , Vacunas de ADN/inmunología

RESUMEN

Mice infected with a recombinant vaccinia virus (VVplp) encoding the myelin proteolipid protein (PLP) and then challenged with the encephalitogenic peptide, PLP139-151, developed a more severe acute attack vs. control mice. Following this initial acute attack, vaccinated mice had significantly less clinical disease (relapses) than control vaccinated or mock vaccinated mice. Control mice developed a relapsing-remitting disease with severe clinical relapses. During the remission state in VVplp vaccinated mice, histopathologic changes were markedly reduced in the central nervous system (CNS) vs. control vaccinated or unvaccinated mice. Inflammation was mainly limited to the meninges with a reduction of mononuclear cells in the parenchyma of the spinal cord in VVplp vaccinated and PLP139-151 challenged mice vs. control mice where inflammatory changes with demyelination was observed. During the remission period an increase in IL-4 was seen. In addition, there was significantly less T cell proliferation to PLP139-151 that was confirmed by an in vivo measurement of T cell reactivity, DTH responses. This suggests that the almost permanent remission state was dictated by a decreased responsiveness to PLP139-151 in VVplp vaccinated mice.

Asunto(s)

Encefalomielitis Autoinmune Experimental/fisiopatología , Proteína Proteolipídica de la Mielina/genética , Recombinación Genética/fisiología , Virus Vaccinia/genética , Vaccinia/fisiopatología , Enfermedad Aguda , Animales , Enfermedad Crónica , Citocinas/metabolismo , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Epítopos , Femenino , Ratones , Ratones Endogámicos , Proteína Proteolipídica de la Mielina/inmunología , Vaina de Mielina/patología , Fragmentos de Péptidos/inmunología , Recurrencia , Factores de Tiempo , Vacunación , Vacunas Virales/farmacología

RESUMEN

Sporadically occurring non-suppurative encephalitis appears to be a frequent condition of Swiss cattle. Fifty-one such cases diagnosed over a period of 10 years were examined retrospectively to investigate whether they constituted one or more distinct diseases, and to search for aetiological agents. Three cases were characterised by periventricular granulomatous encephalitis, and most probably represented a different disease, but the remaining 48 cases had disseminated non-suppurative encephalitis with widespread neuronal changes. Neuronal degeneration was very marked in the hippocampus of 10 cases and in the cerebellar Purkinje cells of 11. It was thought that the latter cases represented morphological variations of the same disease rather than a different disease because of their overlapping morphological features. The 48 cases had the following features in common: the disease had primarily neurological signs affecting mostly adult cattle, it was a sporadic condition, and there was a clear tendency for it to have a subacute to chronic course. Polymerase chain reaction (PCR) amplification for chlamydial DNA was negative except in one of 32 specimens, and immunohistochemistry did not demonstrate the presence of chlamydial antigens either in the one PCR-positive case or in the other cases examined. Immunohistochemistry for rabies virus, Borna disease virus, and central European tickborne encephalitis virus was negative. In four cases, immunolabelled cells were found in the lesions with antibodies against paramyxovirus antigens.

Asunto(s)

Enfermedades de los Bovinos/patología , Encefalomielitis/veterinaria , Meningoencefalitis/veterinaria , Animales , Bovinos , Enfermedades de los Bovinos/etiología , Cerebelo/patología , Encefalomielitis/etiología , Encefalomielitis/patología , Hipocampo/patología , Meningoencefalitis/etiología , Meningoencefalitis/patología , Reacción en Cadena de la Polimerasa , Médula Espinal/patología , Suiza

RESUMEN

In situ hybridization, (ISH) using a digoxigenin-antisense RNA-probe to detect chlamydial rRNA was applied to post mortem tissue of birds. The technique was optimized and validated using tissue from experimentally-infected chicken embryos. Tissue sections were also tested by immunohistochemistry (peroxidase-antiperoxidase reaction, PAP) for the presence of chlamydial antigen using a genus specific monoclonal antibody. In the chicken embryo tissue, ISH and PAP were comparably sensitive and specific (100% and 100%, respectively). ISH and PAP in general were correlated to microscopic lesions. For further comparison, ISH with PAP was applied retrospectively to tissues of 82 birds from which Chlamydia had been isolated, or which were suggestive of chlamydiosis. Using in situ hybridization 47 of 82 birds were found to be positive, and as were 23 of 82 birds with PAP. None of the ISH-only positive cases were found to be strongly positive. On the other hand, cases which were found positive with the ISH were also positive with other methods (PAP and isolation of Chlamydiae from chicken embryos). There was no close correlation between the positive cells and histological lesions. In spite of the higher sensitivity and specificity of the ISH, this technique is not suitable for routine diagnostic investigations. ISH is expensive, laborious, and time consuming.

Asunto(s)

Enfermedades de las Aves/microbiología , Infecciones por Chlamydia/veterinaria , Chlamydia/aislamiento & purificación , Hibridación in Situ/veterinaria , Psittaciformes , Animales , Enfermedades de las Aves/diagnóstico , Embrión de Pollo , Chlamydia/genética , Infecciones por Chlamydia/diagnóstico , Infecciones por Chlamydia/microbiología , Técnicas para Inmunoenzimas/veterinaria , ARN Bacteriano/análisis

RESUMEN

This report describes a two-year-old White Alpine ram with suppurative pleuropneumonia and a lung abscess. Prior to admission, the ram had been unsuccessfully treated with antibiotics and levamisole. Clinical examination revealed that the general behaviour and condition of the ram were severely disturbed. The rectal temperature and respiratory rate were increased. Auscultation of the lungs revealed increased vesicular sounds. Based on clinical findings, a tentative diagnosis of bronchopneumonia was made. To confirm the diagnosis, blood was taken for serological testing for Maedi-Visna, and endoscopic examination of the respiratory tract and ultrasonographic and radiographic examination of the thorax were performed. Cytologic and bacteriologic examination of tracheal secretions revealed large numbers of neutrophils and Actinomyces pyogenes organisms. A pocket of gas, surrounded by a capsule of soft tissue density, overlying the base of the heart, and a horizontal fluid line were observed on radiographs. Ultrasonographic examination revealed an effusion between the pleura and the lung on the left side of the thorax; an encapsulated abscess was seen on the right side of the thorax. Centesis and aspiration of this accumulation of fluid yielded foul-smelling pus. Post mortem examination confirmed the clinical, radiographic and ultrasonographic findings. The ram had severe chronic suppurative pleuropneumonia with abscess formation between the pleura and lung on the right side.

Asunto(s)

Actinomicosis/veterinaria , Absceso Pulmonar/veterinaria , Pleuroneumonía/veterinaria , Enfermedades de las Ovejas/diagnóstico por imagen , Actinomyces/aislamiento & purificación , Actinomicosis/diagnóstico por imagen , Animales , Absceso Pulmonar/diagnóstico por imagen , Masculino , Pleuroneumonía/diagnóstico por imagen , Radiografía , Ovinos , Supuración/veterinaria , Ultrasonografía

RESUMEN

Continuous infusion of intravenous anesthetics can be achieved either by a manually controlled infusion (MCI) pump, or by a computer-assisted continuous infusion (CACI) pharmacokinetic model-driven infusion system. Randomized double-blind comparisons of the two infusion systems for general anesthesia were performed in 24 patients undergoing coronary artery bypass grafting. Patients were allocated to receive continuous infusions of midazolam and fentanyl by either a MCI device or CACI. Midazolam and fentanyl infusions were independently titrated to maintain hemodynamic stability, defined as mean arterial pressure (MAP) and heart rate (HR) within 20% of baseline values. As directed by the study design, comparable hemodynamic control was achieved in both groups. Mean plasma fentanyl concentrations measured at specific timepoints were similar between groups. The plasma midazolam level for induction was 196 +/- 139 ng/mL in the CACI group and 300 +/- 128 ng/mL in the MCI group, and the fentanyl level was similar in both groups, 6.7 +/- 1.9 ng/mL in CACI and 6.3 +/- 4.6 ng/mL in the MCI group. The drug levels were lower (P < or = .05) for midazolam during maintenance of anesthesia and similar for fentanyl during the maintenance of anesthesia. In the MCI group, the average duration of anesthesia was 246.5 +/- 35.0 minutes, with a mean total fentanyl dose of 30.27 +/- 11.14 micrograms/kg. In the CACI group, the average duration of anesthesia was 230.8 +/- 44.1 minutes, with a mean total fentanyl dose of 34.61 +/- 5.40 micrograms/kg (P > 0.05 for comparisons between groups for duration of anesthesia and total fentanyl dose).(ABSTRACT TRUNCATED AT 250 WORDS)

Asunto(s)

Anestesia Intravenosa , Puente de Arteria Coronaria , Fentanilo/administración & dosificación , Bombas de Infusión , Midazolam/administración & dosificación , Presión Sanguínea/fisiología , Método Doble Ciego , Quimioterapia Asistida por Computador/instrumentación , Femenino , Fentanilo/sangre , Fentanilo/farmacocinética , Predicción , Frecuencia Cardíaca/fisiología , Humanos , Intubación Intratraqueal , Masculino , Midazolam/sangre , Midazolam/farmacocinética , Persona de Mediana Edad , Monitoreo Intraoperatorio , Placebos , Factores de Tiempo

RESUMEN

We evaluated the effects of clenbuterol HCl (0.8 micrograms/kg, of body weight, IV), a beta 2 agonist, on ventilation-perfusion matching and hemodynamic variables in anesthetized (by IV route), laterally recumbent horses. The multiple inert gas elimination technique was used to assess pulmonary gas exchange. Clenbuterol HCl induced a decrease in arterial oxygen tension (from 57.0 +/- 1.8 to 49.3 +/- 1.2 mm of Hg; mean +/- SEM) as a result of increased shunt fraction (from 6.6 +/- 2.1 to 14.4 +/- 3.1%) and ventilation to regions with high ventilation-perfusion ratios. In contrast, no changes in these variables were found in horses given sterile water. In horses given clenbuterol HCl, O2 consumption increased from 2.23 +/- 0.18 to 2.70 +/- 0.14 ml.min-1.kg-1, and respiratory exchange ratio decreased from 0.80 +/- 0.02 to 0.72 +/- 0.01. Respiratory exchange ratio and O2 consumption were not significantly modified in sterile water-treated (control) horses. Clenbuterol HCl administration was associated with increased cardiac index (from 57.4 +/- 4.0 to 84.2 +/- 6.3 ml.min-1.kg-1), decreased total peripheral vascular resistance (from 108.3 +/- 9.3 to 47.6 +/- 2.8 mm of Hg.s.kg.ml-1), and decreased pulmonary vascular resistance (from 31.3 +/- 3.8 to 13.6 +/- 0.7 mm of Hg.s.kg.ml-1). Our findings indicated that clenbuterol HCl may potentiate hypoxemia as a result of increased shunt fraction in horses anesthetized by the IV route, and caused changes in hemodynamic variables that were consistent with its ability to stimulate beta 2-adrenergic receptors.

Asunto(s)

Clenbuterol/farmacología , Hemodinámica/efectos de los fármacos , Caballos/fisiología , Pulmón/fisiología , Consumo de Oxígeno/efectos de los fármacos , Circulación Pulmonar/efectos de los fármacos , Anestesia General/veterinaria , Animales , Temperatura Corporal/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Pulmón/efectos de los fármacos , Respiración/efectos de los fármacos , Resistencia Vascular/efectos de los fármacos

RESUMEN

We reviewed over 220 cases of acute carbon monoxide (CO) poisoning and now report on 17 patients whose poisoning occurred from the indoor use of propane-fueled forklifts. All patients in this series presented with neurologic symptoms or persistent headache and were given hyperbaric oxygen to resolve their symptomatology. We investigated the concentration of CO in the exhaust emissions of 12 propane-fueled forklifts used in various workplaces in our location. The average CO concentration in the exhaust during engine idling was 36,000 parts per million (3.6%). This value decreased slightly to 30,000 ppm (3.0%) at working engine speed. Measurements of exhaust flow indicate CO production rates of approximately 60 liters per minute at working engine speed. These quantities of CO constitute a significant occupational exposure risk to workers using propane-fueled forklifts in unventilated indoor environments.

Asunto(s)

Intoxicación por Monóxido de Carbono/etiología , Equipos y Suministros , Cefalea/inducido químicamente , Enfermedades Profesionales/inducido químicamente , Propano/efectos adversos , Enfermedad Aguda , Adulto , Monóxido de Carbono/análisis , Femenino , Humanos , Oxigenoterapia Hiperbárica , Masculino , Persona de Mediana Edad , Estados Unidos

RESUMEN

Currently, alpha interferon is the only recognized therapy for chronic viral hepatitis. As a result of its success in several multicenter trials, the agent was approved recently by the FDA for use in the clinical management of patients with chronic hepatitis C. FDA approval for its use in chronic hepatitis B is anticipated. Based upon this experience in nonimmunosuppressed individuals, the efficacy of alpha interferon therapy in patients who are recipients of liver allografts and are receiving chronic immunosuppression was assessed in a preliminary trial of the agent in 30 patients (13 with HBV, 11 with HCV, and 6 with hepatitis non A, non B, non C). Therapy was initiated at a dose of 3 X 10(6) units three times per week and continued for 6 months. Dose reduction in the amount of the alpha interferon administered was determined by a preestablished protocol. Nine percent of those with HCV and 18% of those with hepatitis non A, non B, non C experienced a full response to alpha interferon therapy. No full responses to alpha interferon therapy. No full responses were seen in those with HBV disease. Partial responses were common in all three groups but were most frequent in those with hepatitis non A, non B, non C and least frequent in those with HCV-related disease. This preliminary experience demonstrates the following: 1. Viral hepatitis following OLTx can be treated with alpha-2b-interferon. 2. The complications of alpha-2b-interferon therapy utilized prior to OLTx can be avoided by giving the therapy following successful OLTx. 3. The high rate of partial responses noted suggests that future studies should utilize either higher doses or longer durations of therapy or both. 4. The response rate was greatest for those having non A, non B, non C hepatitis and least for those with HCV hepatitis. 5. In this small preliminary series, no episodes of liver graft rejection could be ascribed to the use of alpha-2b-interferon in the patients so treated.

Asunto(s)

Hepatitis Viral Humana/terapia , Interferón-alfa/uso terapéutico , Trasplante de Hígado , Hepatitis C/terapia , Humanos , Interferón alfa-2 , Complicaciones Posoperatorias/terapia , Proteínas Recombinantes , Trasplante Homólogo

RESUMEN

The histologic findings in the original liver obtained from 9 liver allograft patients with active B virus hepatitis were compared with 28 posttransplant pathology specimens. All specimens were studied with the use of light and immunohistochemical microscopy in conjunction with pertinent clinical data. Eight of the 9 patients had chronic active hepatitis B (HB) with cirrhosis, prior to transplant, one of which had coexistent hepatocellular carcinoma. The ninth patient had fulminant hepatic necrosis secondary to acute HB prior to transplantation. In all of the patients with chronic HB prior to transplantation who survived more than 2 months after transplantation recurrent infection of the graft developed despite perioperative HB immunoglobulin therapy. The patient with acute fulminant hepatitis B pretransplant has done well postoperatively and has evidence of HB virus immunity (positive anti-HBs) 15 months after transplantation. Examination of tissue specimens obtained during episodes of allograft dysfunction in these 9 patients indicate that pathologic alterations of active HB infection of the allograft are associated with a preferential lobular insult, whereas those occurring in rejection preferentially involve portal tract structures. Serologic data combined with biopsy histopathologic data are essential in distinguishing between the two quite different events.

Asunto(s)

Rechazo de Injerto , Hepatitis B/cirugía , Trasplante de Hígado , Diagnóstico Diferencial , Hepatitis B/diagnóstico , Hepatitis B/patología , Hepatitis B/terapia , Humanos , Inmunoterapia , Recurrencia